Print

2019/2020 Universal Influenza Immunization Program (UIIP)

The following provides information about the Ontario Ministry of Health (the ministry's) Universal Influenza Immunization Program (UIIP) for the 2019/2020 influenza season. The UIIP offers influenza vaccine free of charge each year to all individuals six months of age and older who live, work or go to school in Ontario.

Contents

Immunization of High-Risk Groups

As in previous years, groups at high risk and those capable of transmitting influenza to them should be immunized as soon as influenza vaccine is available.

Influenza immunization for the general population began on October 30, 2019, the date of the UIIP kick-off.

Individuals in the following three groups are particularly recommended to receive the influenza vaccine as soon as it becomes available:

  1. Individuals at high risk of influenza-related complications or who are more likely to require hospitalization:
    • All pregnant women
    • People who are residents of nursing homes or other chronic care facilities
    • People ≥ 65 years of age
    • All children 6 to 59 months of age
    • Indigenous peoples
    • Adults or children 6 months of age and over with chronic health conditions as follows:
      • cardiac or pulmonary disorders
      • diabetes mellitus or other metabolic disease
      • cancer
      • conditions or taking medication which compromise the immune system (due to underlying disease, therapy or both)
      • renal disease
      • anemia or hemoglobinopathy
      • neurologic or neurodevelopmental conditions
      • morbid obesity (body mass index of ≥ 40)
      • children and adolescents (6 months to 18 years) undergoing treatment with acetylsalicylic acid for long periods
  2. Individuals capable of transmitting influenza to those listed in #1 and/or to infants under 6 months of age:
    • Health care workers and other care providers in facilities and community settings
    • Household contacts (adults and children) of individuals at high risk of influenza related complications
    • Persons who provide care to children ≤ 59 months of age
    • Those who provide services within a closed or relatively closed setting to persons at high risk (e.g., crew on a ship)
  3. Swine and poultry industry workers.

UIIP Influenza Vaccine Products

Table 1: Publicly funded influenza vaccines available through the 2019/2020 UIIP
Vaccine products Quadrivalent Inactivated Vaccine (QIV) High-Dose Trivalent Inactivated Vaccine (high-dose TIV)
FluLaval Tetra Fluzone® Quadrivalent Afluria® Tetra Fluzone® High-Dose
Micrograms of HA 15 µg 15 µg 15 µg 60 µg
Dosage 0.5mL 0.5mL 0.5mL 0.5mL
Format Multi-dose vial Multi-dose Vial (MDV) Prefilled syringe (PFS) Prefilled syringe Prefilled syringe
Administration Route Intramuscular injection Intramuscular injection Intramuscular injection Intramuscular injection
Age indications
6 months 6 months 5 years 65 years
Most common allergens Egg Protein*
Thimerosal
MDV Egg Protein*
Thimerosal
PFS Egg Protein*
Egg Protein*
Neomycin
Polymyxin B
Egg Protein*
Post-Puncture Shelf Life 28 days^
MDV 28 days^
PFS N/A
N/A N/A

Package Dimensions
in cm
(l x w x h)

2.7 x 2.7 x 6.9
MDV 3 x 2.9 x 6.2
PFS 10.4 x 8.9 x 3.8
12.7 x 6.35 x 9.4 10 x 9 x 2.2

* The National Advisory Committee on Immunization (NACI) indicates that egg-allergic individuals may be vaccinated against influenza using the full dose of any appropriate product, including QIV and high-dose TIV
^ Return vials with remaining doses to PHU or OGPMSS (for Toronto clients) as wastage
HA refers to hemagglutinin

Important Notes:

UIIP Vaccines for Specific Age Groups:

Table 2: Publicly funded influenza vaccine eligibility for specific age groups
Age Group Quadrivalent Inactivated Vaccine (QIV) High-Dose TIV
  FluLaval Tetra Fluzone® Quadrivalent Afluria® Tetra Fluzone® High-Dose
6 months up to and including 4 years    
5 years up to and including 64 years  
≥65 years

Note: NACI has not identified any preference between high-dose TIV and QIV products for individuals 65 years of age and older.

Product Availability

Timing of Product Availability

Table 3: Typical UIIP Vaccine Supply Timeline
 
Provincial Vaccine Supply
Mid to late-September The province begins receiving its initial supply of influenza vaccine doses in multiple shipments from manufacturers.
Early- to mid-October The province continues to receive shipments of influenza vaccine throughout October from the manufacturers.
Mid to late-October Provincial influenza vaccine supply is replenished following immunization of high priority groups and additional shipments from vaccine manufacturers.
November onward Province orders additional doses as required from vaccine manufacturers.

Vaccine Wastage and Cold Chain Requirements

Program Specific Information

Additional Resources and Information

Questions

For More Information

Please e-mail uiip.moh@ontario.ca or call Service Ontario, INFOline at 1 877-844-1944